|
Name: ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide)
Type: Synthetic cannabinoid
AKA: ADB-BUTINACA
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
ADB-BUTINACA, a synthetic cannabinoid, was first identified in the 2010s. It was developed as a potent cannabinoid receptor agonist with similar effects to THC. The compound appeared in synthetic cannabis products and gained popularity for its psychoactive effects. ADB-BUTINACA's health risks and potency have led to increased regulatory measures.
|
|
V. Legal Information
ADB-BUTINACA is a synthetic cannabinoid with high abuse potential. It is classified under Schedule I in the United States and similarly regulated globally to manage its misuse and impact on public health. Regulations aim to prevent its distribution and use. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
ADB-BUTINACA is a synthetic cannabinoid with potent psychoactive effects. It increases heart rate and blood pressure. Short-term use may produce intense psychoactive effects, while long-term use poses risks of cardiovascular issues and psychological problems. Overdose risks include severe agitation, hallucinations, and cardiovascular effects. Safe use requires cautious dosing and monitoring. Recent research explores its psychoactive effects and associated health risks.  |
|
VII. Psychological Effects
ADB-BUTINACA, a synthetic cannabinoid, affects cannabinoid receptors, leading to euphoria, altered perception, and relaxation. Immediate effects include mood elevation and sensory distortions, lasting several hours. Long-term use may result in severe psychological effects, including paranoia and cognitive impairments. Research emphasizes its potential for psychological dependence and mental health risks.
 |
|
VIII. Culture
ADB-Butinaca is a synthetic cannabinoid with no historical or cultural lore, emerging in the recent synthetic drug market. Its cultural significance lies in its use as a legal high and the associated health and legal challenges. Proponents of synthetic cannabinoids highlight their effects and legal status in certain regions, while opponents warn of health risks and unpredictable effects. Its use is primarily recreational, reflecting broader issues in synthetic drug regulation and public health.
 |